• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 課題ページに戻る

2022 年度 実施状況報告書

Spatiotemporal metabolomics analysis in the human cornea-on-a-chip for the determination of ocular drug toxicity

研究課題

研究課題/領域番号 22K14548
研究機関立命館大学

研究代表者

ABDALKADER Rodi  立命館大学, 立命館グローバル・イノベーション研究機構, 助教 (20839964)

研究期間 (年度) 2022-04-01 – 2024-03-31
キーワードCornea-on-a-chip / Microfluidic / Metabolomic / Drug toxicity
研究実績の概要

This research aims to identify metabolite markers related to drug toxicity using untargeted metabolomic analysis in a human corneal epithelium-on-a-chip. In the current fiscal year, an untargeted metabolic workflow that we previously developed was utilized to analyze extracellular metabolites in human induced pluripotent stem cells (hiPSCs) under early differentiation conditions. A total of 117 metabolites were successfully annotated in a small sample volume of one microliter. This optimized untargeted metabolomic method will be applied to the human corneal epithelium-on-a-chip in the next phase of the study.

現在までの達成度 (区分)
現在までの達成度 (区分)

1: 当初の計画以上に進展している

理由

The progress of this research can be attributed to the successful optimization of the untargeted metabolomic method for detecting extracellular metabolites in both corneal epithelial cells and hiPSCs. Additionally, the establishment of functional corneal epithelial cells from hiPSCs will further facilitate the investigation of drug toxicity in the corneal epithelium-on-a-chip model with greater precision and accuracy.

今後の研究の推進方策

To investigate changes in extracellular metabolites, the untargeted metabolomic method optimized in the previous stage will be applied in the human corneal epithelium-on-a-chip under drug treatment.
In parallel, changes in gene expression under drug treatment will also be investigated. This will be done using transcriptomic analysis to identify differentially expressed genes in response to drug treatment.
Finally, to validate the relationship between changes in extracellular metabolites and gene expression, correlation analysis will be performed to identify any significant associations between the two. These results will provide a more comprehensive understanding of drug toxicity related metabolite markers and their underlying mechanisms.

次年度使用額が生じた理由

The budget allocated for this research project will be utilized to purchase reagents and human induced pluripotent stem cell culturing tools, as well as to cover expenses for attending international or domestic meetings and publishing the research findings. The applicant intends to utilize the budget within the current fiscal year to ensure the timely completion of the research project.

  • 研究成果

    (4件)

すべて 2023 2022 その他

すべて 雑誌論文 (1件) 学会発表 (2件) (うち国際学会 1件、 招待講演 1件) 備考 (1件)

  • [雑誌論文] Early Differentiation Signatures in Human Induced Pluripotent Stem Cells Determined by Non-Targeted Metabolomics Analysis2023

    • 著者名/発表者名
      Abdalkader Rodi、Chaleckis Romanas、Fujita Takuya
    • 雑誌名

      bioRxiv

      巻: - ページ: -

    • DOI

      10.1101/2023.03.02.530741

  • [学会発表] The survival and characteristics of cryopreserved human iPSC-derived corneal epithelial cells generated by SSM-CI method2022

    • 著者名/発表者名
      Rodi ABDALKADER
    • 学会等名
      World Ophthalmology Congress of the International Council of Ophthalmology (WOC)
    • 国際学会
  • [学会発表] ヒト角膜・オン・チップの開発2022

    • 著者名/発表者名
      Rodi ABDALKADER
    • 学会等名
      第9回大学発シーズ マッチングセミナー」~AgeTech (長寿社会×テクノロジー)特集
    • 招待講演
  • [備考] Personal Website

    • URL

      https://rodialkader.wixsite.com/rodi-abdalkader

URL: 

公開日: 2023-12-25  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi